Evogene(IL:EVGN)
ILA 116.10+6.80 (+6.22%)
IL:EVGN
Evogene earnings date
ILA 116.10
At close:+6.80 (+6.22%)
Evogene (EVGN) Q2 2021 Earnings Report
4 Followers
IL:EVGN Q2 2021 EPS Results
- Actual EPS
- -ILA 478.88
- Consensus EPS
- -ILA 526.76
- Beat/Miss
- Beat by +ILA 47.89
- One Year Ago EPS
- -ILA 525.49
IL:EVGN Q2 2021 Revenue Results
- Actual Revenue
- ILA 43.10M
- Expected Revenue
- ILA 69.60M
- Beat/Miss
- Missed by -ILA 26.50M
- YoY Revenue Growth
- -54.70%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/11/2021
- Time
- Before Open
- Conference Call
- Wednesday, August 11, 2021
IL:EVGN Upcoming Earnings
Evogene's next earnings date is estimated for November 18, 2026, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
IL:EVGN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 18, 2026 | 2026 (Q3) | -60.66- | 141.75 | ― | ― |
| May 20, 2026 | 2026 (Q1) | -86.20-191.55 | -121.32 | -57.89% (-70.24) | |
| Mar 05, 2026 | 2025 (Q4) | -83.01-194.42 | 19.16 | -1115.00% (-213.58) | |
| Mar 05, 2026 | 2026 (Q2) | -86.20-44.70 | -159.63 | 72.00% (+114.93) | |
| Nov 20, 2025 | 2025 (Q3) | -130.89141.75 | -418.22 | 133.89% (+559.96) | |
| Aug 19, 2025 | 2025 (Q2) | -201.13-159.63 | -338.41 | 52.83% (+178.78) | |
| May 21, 2025 | 2025 (Q1) | -161.22-121.32 | -255.4 | 52.50% (+134.09) | |
| Mar 06, 2025 | 2024 (Q4) | -231.4619.16 | -415.03 | 104.62% (+434.18) | |
| Nov 21, 2024 | 2024 (Q3) | -322.44-418.22 | -255.4 | -63.75% (-162.82) | |
| Aug 22, 2024 | 2024 (Q2) | -399.06-338.41 | -542.73 | 37.65% (+204.32) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
